A Single Group Study to Evaluate the Effects of a Multivitamin on a Range of Health and Wellbeing Outcomes.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-23

Study Completion Date

2024-10-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a hybrid single-group clinical trial that will last 12 weeks. Participants will take 2 capsules daily with the first meal of the day in the morning. Participants will undertake blood tests at Baseline and Week 12. Study-specific questionnaires will be completed at Baseline, Week 4, Week 8, and Week 12. Cognitive Battery Testing will take place at Baseline, Week 4, Week 8, and Week 12.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multivitamin for Health and Cognition

NCT07145658

Healthy Cognition Health

ACTIVE_NOT_RECRUITING NA

The Effects of a Nutritional Supplement on Nutrient Status and Quality of Life

NCT06332898

Nutrition, Healthy Gastrointestinal Microbiome Healthy Aging

COMPLETED NA

A Study to Assess the Impact of a Nutritional Supplement on Wellbeing and Nutrient Absorption

NCT06749808

Nutrition Status

ENROLLING_BY_INVITATION NA

An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits

NCT05523115

Anxiety Stress Memory Deficits +1 more

COMPLETED NA

The Effects of a Multi-vitamin Supplement in Adult Females

NCT03828097

Health, Subjective

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health and Wellbeing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This is a hybrid single-group clinical trial designed to evaluate the effects of a multivitamin on a range of health and wellbeing outcomes over a 12-week period.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

This is an open-label study where no masking will be implemented.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multivitamin Supplement Group

Participants in this arm will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.

Group Type EXPERIMENTAL

Multivitamin Supplement

Intervention Type DIETARY_SUPPLEMENT

: Participants will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multivitamin Supplement

: Participants will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Daily Love Multivitamin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female at birth.
* Aged 18+.
* Interested in supporting their health and wellbeing.
* Not planning to introduce or change prescription medications, vitamins, minerals, or supplements one month prior to and during the study.
* Generally healthy with no uncontrolled chronic conditions.

Exclusion Criteria

* Recent surgeries or invasive treatments.
* Introduction of new health-related products in the last 12 weeks.
* Allergies to product ingredients or use of Epi-Pen.
* Chronic health conditions affecting participation.
* Endocrine or glucose-related disorders, including diabetes.
* Hematological disorders, including anemia.
* Pregnant, breastfeeding, or planning to conceive.
* History of substance abuse or recent smoking.
* Unwillingness to follow the study protocol.
* Participation in other clinical trials.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes